sector

Data-based management consultancy for pharmaceutical companies

Pharmaceutical companies are facing enormous challenges: The industry is characterised by health policy requirements, demographic change, increasing health risks and digital transformation. Added to this are questions of profitability, the shortage of skilled labour and the pressure to bring innovative therapies and medicines to market quickly and efficiently.

Pharmaceutical companies are facing enormous challenges: The industry is characterised by health policy requirements, demographic change, increasing health risks and digital transformation. Added to this are questions of profitability, the shortage of skilled labour and the pressure to bring innovative therapies and medicines to market quickly and efficiently.

IPE supports MedTech companies with customised analyses and strategic consulting. We offer:

  • Cost-benefit analyses and development of new financing strategies, for example in the area of value-based healthcare and health technology assessment
  • Forecasts and scenario analyses to assess future supply needs and technical requirements
  • Analysis of damage caused by illegal trade in medical supplies
  • Assessing the impact of regulatory requirements on innovation and patient care
  • Developing sustainability strategies and analysing the economic and social effects of sustainable supply chains
With our data-based approaches, we help MedTech companies to recognise trends at an early stage, successfully market innovations and secure their long-term competitiveness.

let's

talk

Contact us directly and let's talk about a possible collaboration.

Secret Link